Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact

Affiliations

¹ Department of Ophthalmology, Stein Eye Institute, UCLA Health, University of California, Los Angeles, California.
² Department of Radiological Sciences, Medical Imaging & Informatics Group, University of California, Los Angeles, California.
³ UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of Los Angeles, Los Angeles, California.
⁴ Division of Endocrinology, Department of Medicine, University of California, Los Angeles, California.
⁵ Department of Ophthalmology, Stein Eye Institute, UCLA Health, University of California, Los Angeles, California. Electronic address: etsui@mednet.ucla.edu.

Free article

Leila Chew et al. Ophthalmol Retina. 2025.

Free article

. 2025 Nov 11:S2468-6530(25)00507-X.

doi: 10.1016/j.oret.2025.11.001. Online ahead of print.

¹ Department of Ophthalmology, Stein Eye Institute, UCLA Health, University of California, Los Angeles, California.
² Department of Radiological Sciences, Medical Imaging & Informatics Group, University of California, Los Angeles, California.
³ UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of Los Angeles, Los Angeles, California.
⁴ Division of Endocrinology, Department of Medicine, University of California, Los Angeles, California.
⁵ Department of Ophthalmology, Stein Eye Institute, UCLA Health, University of California, Los Angeles, California. Electronic address: etsui@mednet.ucla.edu.

No abstract available

Keywords: Immune checkpoint inhibitors; Immunotherapy; Uveitis.

LinkOut - more resources